Kryza, David <br/><br/>
Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab.  [electronic resource] 

 -  Bioconjugate chemistry  03 2018 
 - 804-812 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1520-4812 
<br/><br/><label>Standard No.: </label>10.1021/acs.bioconjchem.7b00606  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--administration & dosage<br/>Animals<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Drug Carriers--chemistry<br/>Drug Synergism<br/>Female<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Lymphoma--drug therapy<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, SCID<br/>Nanoparticles--chemistry<br/>Rituximab--administration & dosage<br/>Silicon Dioxide--chemistry<br/>Tissue Distribution